Axillary radiotherapy provides alternative to invasive early stage

2013 ASCO Annual Meeting

Axillary radiotherapy provides alternative to invasive early stage breast cancer surgery : Dr Emiel J. Rutgers

Listen now

Description

Dr Emiel J. Rutgers talks to ecancer at ASCO 2013 on a European phase III clinical trial called AMAROS. The study found that axillary radiotherapy (ART) and lymph node surgery (axillary lymph node dissection, ALND) resulted in equivalent overall and disease-free survival at five years after treatment for women with sentinel lymph node positive early breast cancer. However, a debilitating side effect known as lymphoedema was twice as common among women who underwent surgery.

More Episodes

See all »

Nivolumab produces long-lasting responses in patients with stage IV melanoma: Dr Mario Sznol

Dr Mario Sznol talks to ecancer at ASCO 2013 about long-term follow-up results from an expanded phase I study examining the effects of nivolumab in advanced melanoma. 107 patients were treated with five different doses of nivolumab. All patients had disease that worsened despite prior standard...

Published 06/13/13

ASCO 2013 highlights

Dr Swchwartz gives ecancertv his ASCO 2013 highlights. He covers the latest promising news in melanoma and comments on the potential of immunotherapy and antibodies for treatment of other cancers.

Published 06/13/13

Affects of The Cancer Genome Atlas

Dr Matthew Ellis talks to ecancer at ASCO 2013 about the affects of The Cancer Genome Atlas on research, treatment and next generation sequencing.

Published 06/13/13